Shangfeng Gao

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Journal of cellular and molecular medicine

Exploration of targeted anti-tumor therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Zixuan Zhou, Bingxin Zhu, Qingming Meng, Tong Zhang, Yihao Wu, Hengliang Shi, Shangfeng Gao
Research progress in molecular pathology markers in medulloblastoma. Exploration of targeted anti-tumor therapy 4 (1) (2023)
Zixuan Zhou, Bingxin Zhu, Qingming Meng, Tong Zhang, Yihao Wu, Hengliang Shi, Shangfeng Gao
Research progress in molecular pathology markers in medulloblastoma. Exploration of targeted anti-tumor therapy 4 (1) (2023)
Xuejiao Liu, Chenglong Yue, Lin Shi, Guanzheng Liu, Qiyu Cao, Qianqian Shan, Yifeng Wang, Xiangyu Chen, Huan Li, Jie Wang, Shangfeng Gao, Mingshan Niu, Hengliang Shi
MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation. Journal of cellular and molecular medicine 24 (13) (2020)
Yunnong Song, Cheng Li, Lei Jin, Jingsong Xing, Zhuang Sha, Tong Zhang, Daofei Ji, Hengliang Shi, Shangfeng Gao
RIOK2 is negatively regulated by miR-4744 and promotes glioma cell migration/invasion through epithelial-mesenchymal transition. Journal of cellular and molecular medicine 24 (8) (2020)